Consumers Who Have Used Zantac® And Are Now Suffering From Certain Cancers Are Urged To Request a Free Case Evaluation For Justice and Substantial Compensation
Consumers Who Have Used Zantac® And Are Now Suffering From Certain Cancers Are Urged To Request a Free Case Evaluation For Justice and Substantial Compensation
Some of the bladder cancer symptoms that consumers of Zantac® (aka ranitidine®) consumers should be wary of may include:
- Blood or blood clots in the urine;
- Pain or burning sensation during urination;
- Frequent urination;
- Feeling the need to urinate many times throughout the night;
- Feeling the need to urinate, but not being able to pass urine; and,
- Lower back pain on one side of the body.
FREE CLAIM REVIEW
By clicking the "Free Case Review" button, I consent to receive recurring auto dialed and/or pre-recorded telemarketing calls and/or text messages from Shield Legal LP or our partners in order to discuss my legal options and at the telephone number I provided. I also consent to the Shield Legal LP Privacy Policy and Terms of Use. I understand that I may receive a call even if my telephone number is listed on a Do Not Call list and that my consent is not a requirement of purchase. I understand that my telephone company may impose charges on me for these contacts and that I can revoke this consent at any time. For SMS campaigns: Text STOP to cancel and HELP for help. Msg & data rates may apply. Recurring msgs up to 27 msgs per month.
100% confidential Case Evaluations
Answer a few basic questions to get started
Receive a confidential case evaluation
Have an individual claim filed for compensation
Billions in profits made on unsafe Medication
How does Zantac® (aka ranitidine®) cause bladder cancer?
Glaxo Holdings Ltd® (aka GSK® or GlaxoSmithKline®) created and sold Zantac® beginning in 1983 to reduce excess acid produced in stomach cells.
It was first approved for short-term use only by the Federal Drug Administration (FDA) for its potential to cause cancer if prescribed in long-term use–however, Zantac® began being marketed for long-term maintenance use.
Since over-the-counter Zantac® (aka ranitidine®) contains high levels of the potentially dangerous chemical N-nitrosodimethylamine (NDMA), it has potentially been linked to several types of lifelong cancers–including bladder cancer.
- The FDA advises the public to not ingest more than 96 nanograms of NDMA daily.
- Although food and water can both be contaminated with NDMA, the known levels of the chemical aren’t enough to cause actual harm.
- One 150mg tablet of ranitidine showed more than 47,000 nanograms of NDMA in urine samples tested.
We believe that these bladder cancer victims should get the compensation and justice they deserve by addressing the makers of Zantac® (aka ranitidine®) in a court of law.
Zantac® and Bladder Cancer in the News
2021
The FDA told all manufacturers to stop selling Zantac made with ranitidine in the United States in April 2020 because NDMA contamination can increase over time.
2021
New Study Suggests Those Taking Zantac at a Higher Risk for Bladder Cancer
2020
Because of the commonality of facts and claims, all Zantac lawsuits were consolidated into the U.S. District Court for the Southern District of Florida on February 6, 2020.
